|
 |
|
Cancer Diagnostics: Major Suppliers Strategic Assessments
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
|
 |
|
$2500.00 |
| |
|
|
|
UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2450.00 |
| |
|
|
|
Cancer Diagnostic Test Volume and Sales Forecasts by Country
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables
|
|
|
$2450.00 |
| |
|
|
|
Analysis of the French Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including:Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the German Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 533 pages, 40 tables, and presents a comprehensive analysis of the German hospital cancer diagnostics market, including:Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Italian Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including:Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Japanese Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Spanish Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including:Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the UK Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital cancer diagnostics market, including:Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the US Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including:Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years.
|
|
|
$2200.00 |
| |
|
|
|
World Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.
|
|
|
$1950.00 |
| |
|
|
|
Cancer Diagnostic Technologies: Assessment of Emerging Technologies and Market Applications
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.Contains 110 pages
|
|
|
$1850.00 |
| |
|
|
|
Cancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.Contains 25 pages
|
|
|
$950.00 |
| |
|
|
|
The US Cancer Diagnostic Testing Market: Sales Forecasts
By Market Segment and Supplier Shares by Test
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$850.00 |
| |
|
|
|
France Cancer Diagnostic Testing Market: Sales Forecasts
By Market Segment and Supplier Shares by Test
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Germany Cancer Diagnostic Testing Market: Sales Forecasts
By Market Segment and Supplier Shares by Test
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Italy Cancer Diagnostic Testing Market: Sales Forecasts
By Market Segment and Supplier Shares by Test
This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Japan Cancer Diagnostic Testing Market: Sales Forecasts
By Market Segment and Supplier Shares by Test
This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
|